<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chung MK</submitter><funding>BLRD VA</funding><funding>NHLBI NIH HHS</funding><pagination>e17-e91</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11062890</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(9)</volume><pubmed_abstract>Cardiac physiologic pacing (CPP), encompassing cardiac resynchronization therapy (CRT) and conduction system pacing (CSP), has emerged as a pacing therapy strategy that may mitigate or prevent the development of heart failure (HF) in patients with ventricular dyssynchrony or pacing-induced cardiomyopathy. This clinical practice guideline is intended to provide guidance on indications for CRT for HF therapy and CPP in patients with pacemaker indications or HF, patient selection, pre-procedure evaluation and preparation, implant procedure management, follow-up evaluation and optimization of CPP response, and use in pediatric populations. Gaps in knowledge, pointing to new directions for future research, are also identified.</pubmed_abstract><journal>Heart rhythm</journal><pubmed_title>2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.</pubmed_title><pmcid>PMC11062890</pmcid><funding_grant_id>R01 HL158071</funding_grant_id><funding_grant_id>P01 HL158502</funding_grant_id><funding_grant_id>IK6 BX006185</funding_grant_id><pubmed_authors>Parkash R</pubmed_authors><pubmed_authors>Chung EH</pubmed_authors><pubmed_authors>Cha YM</pubmed_authors><pubmed_authors>Tang WHW</pubmed_authors><pubmed_authors>Cygankiewicz I</pubmed_authors><pubmed_authors>Seow SC</pubmed_authors><pubmed_authors>Shen WK</pubmed_authors><pubmed_authors>Srivatsa UN</pubmed_authors><pubmed_authors>Chung MK</pubmed_authors><pubmed_authors>Stecker EC</pubmed_authors><pubmed_authors>Dandamudi G</pubmed_authors><pubmed_authors>Slotwiner DJ</pubmed_authors><pubmed_authors>Varma N</pubmed_authors><pubmed_authors>Gold MR</pubmed_authors><pubmed_authors>Cronin EM</pubmed_authors><pubmed_authors>Kron J</pubmed_authors><pubmed_authors>Tanawuttiwat T</pubmed_authors><pubmed_authors>Gutierrez A</pubmed_authors><pubmed_authors>Tracy CM</pubmed_authors><pubmed_authors>Link MS</pubmed_authors><pubmed_authors>Arora V</pubmed_authors><pubmed_authors>Singh JP</pubmed_authors><pubmed_authors>Lau CP</pubmed_authors><pubmed_authors>Worsnick SA</pubmed_authors><pubmed_authors>Tapias CA</pubmed_authors><pubmed_authors>Gorodeski EZ</pubmed_authors><pubmed_authors>Karpawich PP</pubmed_authors><pubmed_authors>Curtis AB</pubmed_authors><pubmed_authors>Vernooy K</pubmed_authors><pubmed_authors>Zeitler EP</pubmed_authors><pubmed_authors>Gopinathannair R</pubmed_authors><pubmed_authors>Guzman JC</pubmed_authors><pubmed_authors>Pathak RK</pubmed_authors><pubmed_authors>Kutyifa V</pubmed_authors><pubmed_authors>Dal Forno ARJ</pubmed_authors><pubmed_authors>Patete MF</pubmed_authors><pubmed_authors>Kiehl EL</pubmed_authors><pubmed_authors>Patton KK</pubmed_authors><pubmed_authors>Goldberger ZD</pubmed_authors><pubmed_authors>Zareba W</pubmed_authors><pubmed_authors>Indik JH</pubmed_authors><pubmed_authors>Park SJ</pubmed_authors><pubmed_authors>Sridhar ARM</pubmed_authors><pubmed_authors>Glotzer TV</pubmed_authors><pubmed_authors>Schoenfeld MH</pubmed_authors><pubmed_authors>Karim S</pubmed_authors><pubmed_authors>Vijayaraman P</pubmed_authors><pubmed_authors>Ensch DP</pubmed_authors><pubmed_authors>Al-Khatib SM</pubmed_authors><pubmed_authors>Khaykin Y</pubmed_authors><pubmed_authors>Dubin AM</pubmed_authors><pubmed_authors>Rickard J</pubmed_authors><pubmed_authors>Shoda M</pubmed_authors><pubmed_authors>Marine JE</pubmed_authors><pubmed_authors>Huang W</pubmed_authors><pubmed_authors>Upadhyay GA</pubmed_authors><pubmed_authors>Mullens W</pubmed_authors><pubmed_authors>Birgersdotter-Green UM</pubmed_authors><pubmed_authors>Imrey PB</pubmed_authors><pubmed_authors>Perona CA</pubmed_authors></additional><is_claimable>false</is_claimable><name>2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.</name><description>Cardiac physiologic pacing (CPP), encompassing cardiac resynchronization therapy (CRT) and conduction system pacing (CSP), has emerged as a pacing therapy strategy that may mitigate or prevent the development of heart failure (HF) in patients with ventricular dyssynchrony or pacing-induced cardiomyopathy. This clinical practice guideline is intended to provide guidance on indications for CRT for HF therapy and CPP in patients with pacemaker indications or HF, patient selection, pre-procedure evaluation and preparation, implant procedure management, follow-up evaluation and optimization of CPP response, and use in pediatric populations. Gaps in knowledge, pointing to new directions for future research, are also identified.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2026-05-03T03:28:59.91Z</modification><creation>2026-04-07T18:48:03.24Z</creation></dates><accession>S-EPMC11062890</accession><cross_references><pubmed>37283271</pubmed><doi>10.1016/j.hrthm.2023.03.1538</doi></cross_references></HashMap>